DEVICES TO MONITOR GLUCOSE LEVELS AND ISCHEMIA
1 Assignment
0 Petitions
Accused Products
Abstract
The disclosure relates to systems, methods, and devices for monitoring a patient'"'"'s blood and cardiac condition. Patients with diabetes oftentimes wear diabetes management equipment (e.g., a glucose monitor, an external insulin pump, or a device having dual functionality). Such patients risk silent myocardial infarction. Herein described is regular cardiac ischemia/infarction monitoring—which if not monitored can lead to (silent) myocardial infarction. Moreover herein described are combined blood monitoring functionality and cardiac condition monitoring functionality via a single device, meaning that the patient is not required to wear additional equipment. Adding this functionality to already-existing equipment is significantly less invasive than requiring a patient to wear one piece of equipment to monitor his/her blood and a second piece of equipment to monitor his/her cardiac condition. This reduction in invasiveness can lead to significantly greater patient participation and compliance, which can improve health and save the lives of many patients.
-
Citations
39 Claims
-
1-17. -17. (canceled)
-
18. A system for managing a patient'"'"'s diabetes and monitoring for cardiac ischemia/infarction in the patient. comprising:
-
diabetes management means for chemically monitoring glucose levels in the patient and/or administering insulin to the patient from an external reservoir; cardiac sensing means for collecting information concerning cardiac ischemia/infarction in the patient; cardiac monitoring circuitry housed by the diabetes management means and adapted to receive at least some of the information concerning the cardiac activity from the cardiac sensing means; and a therapy providing module for providing therapy to the patient, the therapy providing module being housed by the diabetes management means, wherein the cardiac monitoring circuitry is adapted to trigger the therapy providing module based on the information it receives concerning the patient'"'"'s cardiac ischemia/infarction activity. - View Dependent Claims (20, 22, 23, 24, 25, 26, 32, 33, 34, 35)
-
-
19. A system for managing a patient'"'"'s diabetes and monitoring for cardiac ischemia/infarction in the patient, comprising:
-
diabetes management means for chemically monitoring glucose levels in the patient and/or administering insulin to the patient from an external reservoir; cardiac sensing means for collecting information concerning cardiac ischemia/infarction in the patient; cardiac monitoring circuitry housed by the diabetes management means and adapted to receive at least some of the information concerning the cardiac activity from the cardiac sensing means; and an alerting module for alerting the patient and/or a caregiver, the alerting module being housed by the diabetes management means, wherein the cardiac monitoring circuitry is adapted to trigger the alerting module based on the information it receives concerning the patient'"'"'s cardiac activity. - View Dependent Claims (21, 27, 28, 29, 30, 31, 36, 37, 38, 39)
-
Specification